Загрузка...
Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action
Insulin analogs were developed to improve diabetes therapy. However, certain modifications introduced into the insulin molecule were shown to enhance their affinity to the insulin-like growth factor-1 receptor (IGF1R). Most tumors, including endometrial cancers, express high levels of IGF1R. The pre...
Сохранить в:
Главные авторы: | , , , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Frontiers Media S.A.
2018-03-01
|
Серии: | Frontiers in Endocrinology |
Предметы: | |
Online-ссылка: | http://journal.frontiersin.org/article/10.3389/fendo.2018.00105/full |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|